{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:10Z","timestamp":1791332530535,"version":"4.3.1"},"reference-count":17,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"abstract":"<jats:p>OBJECTIVE. Berardinelli-Seip syndrome is a rare congenital lipoatrophy with a severe prognosis and no efficient therapy. Children present with low leptin levels and severe metabolic complications (insulin resistance, elevated triglyceride levels, and hepatic steatosis). The objective of this study was to test safety and efficacy of recombinant-methionyl-human leptin replacement in children with Berardinelli-Seip syndrome before development of severe metabolic disease<\/jats:p>\n               <jats:p>METHODS. As part of an open trial, recombinant-methionyl-human leptin was given daily for 4 months to children who did not have diabetes and had Berardinelli-Seip congenital lipoatrophy and metabolic complications at a dosage that was meant to achieve physiologic levels. Six boys and 1 girl (age: 2.4\u201313.6 years), with a mean fasting insulin level of &amp;gt;15 mIU\/L and hypertriglyceridemia, were included.<\/jats:p>\n               <jats:p>RESULTS. At the end of the recombinant-methionyl-human leptin treatment, a 63% reduction of fasting triglycerides level was achieved. A simultaneous 30% increase in insulin sensitivity was seen, and liver volume was reduced by 20.3%. More remarkable, values of insulin sensitivity and triglyceride level were in the reference range in 4 patients.<\/jats:p>\n               <jats:p>CONCLUSIONS. Leptin replacement is able to reverse metabolic complications in the majority of children with Berardinelli-Seip congenital lipoatrophy and with insulin resistance or dyslipidemia before the development of overt diabetes.<\/jats:p>","DOI":"10.1542\/peds.2006-3165","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T17:53:25Z","timestamp":1185990805000},"page":"e291-e296","source":"Crossref","is-referenced-by-count":71,"title":["Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy"],"prefix":"10.1542","volume":"120","author":[{"given":"Jacques","family":"Beltrand","sequence":"first","affiliation":[{"name":"Universite\u0301 Paris 7, INSERM U690, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Beregszaszi","sequence":"additional","affiliation":[{"name":"Universite\u0301 Paris 7, INSERM U690, Paris, France"},{"name":"Clinical Investigation Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Chevenne","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Sebag","sequence":"additional","affiliation":[{"name":"Pediatric Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"De Kerdanet","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Diabetology, Robert Debre\u0301 Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fre\u0301de\u0301ric","family":"Huet","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Diabetology Unit, South Hospital, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children Hospital, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Tubiana-Rufi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Necker-Enfants Malades Hospital, INSERM EMI363, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lacombe","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Pellegrin Children's Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M.","family":"De Paoli","sequence":"additional","affiliation":[{"name":"Amgen, Inc, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Levy-Marchal","sequence":"additional","affiliation":[{"name":"Universite\u0301 Paris 7, INSERM U690, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,8,1]]},"reference":[{"key":"2021120901535496900_R1","doi-asserted-by":"crossref","unstructured":"Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab.\u20081954;14:193\u2013204","DOI":"10.1210\/jcem-14-2-193"},{"key":"2021120901535496900_R2","doi-asserted-by":"crossref","unstructured":"Seip M, Trygstad O. Generalized lipodystrophy. Arch Dis Child.\u20081963;38:447\u2013453","DOI":"10.1136\/adc.38.201.447"},{"key":"2021120901535496900_R3","doi-asserted-by":"crossref","unstructured":"Jaquet D, Khallouf E, Levy-Marchal C, Czernichow P. Extremely low values of serum leptin in children with congenital generalized lipoatrophy. Eur J Endocrinol.\u20081999;140:107\u2013109","DOI":"10.1530\/eje.0.1400107"},{"key":"2021120901535496900_R4","doi-asserted-by":"crossref","unstructured":"Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med.\u20082002;346:570\u2013578","DOI":"10.1056\/NEJMoa012437"},{"key":"2021120901535496900_R5","doi-asserted-by":"crossref","unstructured":"Ebihara K, Masuzaki H, Nakao K. Long-term leptin-replacement therapy for lipoatrophic diabetes. N Engl J Med.\u20082004;351:615\u2013616","DOI":"10.1056\/NEJM200408053510623"},{"key":"2021120901535496900_R6","doi-asserted-by":"crossref","unstructured":"Javor ED, Cochran EK, Musso C, Young JR, DePaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes.\u20082005;54:1994\u20132002","DOI":"10.2337\/diabetes.54.7.1994"},{"key":"2021120901535496900_R7","doi-asserted-by":"crossref","unstructured":"Petersen KF, Oral EA, Dufour S, Befroy D, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest.\u20082002;109:1345\u20131350","DOI":"10.1172\/JCI0215001"},{"key":"2021120901535496900_R8","doi-asserted-by":"crossref","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol.\u20081979;237:E214\u2013E223","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"2021120901535496900_R9","doi-asserted-by":"crossref","unstructured":"Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab.\u20082000;85:2402\u20132410","DOI":"10.1210\/jcem.85.7.6661"},{"key":"2021120901535496900_R10","doi-asserted-by":"crossref","unstructured":"Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med.\u20081995;1:1155\u20131161","DOI":"10.1038\/nm1195-1155"},{"key":"2021120901535496900_R11","doi-asserted-by":"crossref","unstructured":"Oral EA, Ruiz E, Andewelt A, et al. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab.\u20082002;87:3110\u20133117","DOI":"10.1210\/jcem.87.7.8591"},{"key":"2021120901535496900_R12","doi-asserted-by":"crossref","unstructured":"Cohen P, Friedman JM. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J Nutr.\u20082004;134:2455S\u20132463S","DOI":"10.1093\/jn\/134.9.2455S"},{"key":"2021120901535496900_R13","doi-asserted-by":"crossref","unstructured":"Nijhuis J, Van Dielen FM, Buurman WA, Greve JW. Leptin in morbidly obese patients: no role for treatment of morbid obesity but important in the postoperative immune response. Obes Surg.\u20082004;14:476\u2013483","DOI":"10.1381\/096089204323013451"},{"key":"2021120901535496900_R14","doi-asserted-by":"crossref","unstructured":"Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA.\u20081999;282:1568\u20131575","DOI":"10.1001\/jama.282.16.1568"},{"key":"2021120901535496900_R15","doi-asserted-by":"crossref","unstructured":"Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med.\u20081999;341:879\u2013884","DOI":"10.1056\/NEJM199909163411204"},{"key":"2021120901535496900_R16","doi-asserted-by":"crossref","unstructured":"Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes.\u20081999;48:2039\u20132044","DOI":"10.2337\/diabetes.48.10.2039"},{"key":"2021120901535496900_R17","doi-asserted-by":"crossref","unstructured":"Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab.\u20082002;87:144\u2013147","DOI":"10.1210\/jc.87.1.144"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/2\/e291\/1119214\/zpe0080700e291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/2\/e291\/1119214\/zpe0080700e291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T08:12:07Z","timestamp":1639037527000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/2\/e291\/70433\/Metabolic-Correction-Induced-by-Leptin-Replacement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,8,1]]},"published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-3165","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}